APNHF OTC
Aspen Pharmacare Holdings Limited
1W: +0.0%
1M: +0.0%
3M: +2.3%
YTD: +42.9%
1Y: +73.2%
3Y: -1.7%
5Y: -37.4%
$8.90
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$6.9B
+33.6% ▲
5Y CAGR: +0.2%
Capital Expenditures
$2.1B
+57.5% ▲
5Y CAGR: -8.9%
Free Cash Flow
$4.7B
+4460.5% ▲
5Y CAGR: +6.9%
Dividends Paid
$944M
+41.0% ▲
Buybacks
$482M
-608.1% ▼
Net Change in Cash
$10.1B
+1346.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $8.7B | $7.8B | $7.0B | $1.4B | -$891M |
| Depreciation & Amort. | $1.7B | $1.8B | $2.0B | $0 | $1.9B |
| Stock-Based Comp. | $58M | $135M | $117M | $0 | $0 |
| Change in Working Capital | -$2.7B | -$3.4B | -$242M | -$1.6B | -$241M |
| Other Non-Cash Items | -$780M | -$432M | -$2.6B | $5.3B | $6.1B |
| Operating Cash Flow | $5.4B | $5.5B | $6.2B | $5.2B | $6.9B |
| — Investing Activities — | |||||
| Capital Expenditures | -$2.7B | -$3.2B | -$3.1B | -$5.1B | -$3.0B |
| Acquisitions (Net) | $73M | $317M | -$911M | -$229M | $27.5B |
| Investment Purchases | $2.7B | $0 | $0 | $0 | $0 |
| Investment Sales | $90M | $0 | $0 | $0 | $0 |
| Other Investing | -$2.3B | -$557M | -$5.4B | $68M | $0 |
| Investing Cash Flow | -$2.2B | -$3.4B | -$9.5B | -$5.2B | $24.4B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1.6B | $1.4B | $5.4B | $1.7B | -$19.8B |
| Stock Repurchased | -$1.9B | -$136M | -$56M | -$68M | -$482M |
| Dividends Paid | -$1.2B | -$1.5B | -$1.5B | -$1.6B | -$944M |
| Other Financing | $0 | -$183M | -$201M | -$205M | -$193M |
| Financing Cash Flow | -$4.7B | -$420M | $3.6B | -$162M | -$21.4B |
| Net Change in Cash | -$984M | $2.5B | -$273M | -$811M | $10.1B |
| Cash End of Period | $5.0B | $7.5B | $7.2B | $6.4B | $16.0B |
| Free Cash Flow | $2.7B | $2.3B | $690M | $104M | $4.7B |